Cite
MLA Citation
Olivier Bylicki et al.. “Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018.” European journal of cancer, vol. 183, 2023, pp. 38–48. http://access.bl.uk/ark:/81055/vdc_100180192833.0x00002c